Comex 信息 格瑞那達 30 - pharmaceutical products 3002 - 人体或动物制品

部署報告





圖形 - 格瑞那達 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

圖形 - 格瑞那達 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

表 - 格瑞那達 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
美國 109.639 780.783 344.567 89.989 35.848
韩国 4.000 28.000 250.000 21.000 26.000
荷蘭 13.153 141.608 1.402 51.269 18.224
巴拿馬 180.000
比利時 54.942 42.553
法國 11.705 13.936 32.287 21.581
愛爾蘭 7.258 10.784 13.940 20.034
德國 6.701 10.400 5.093 6.155 8.423
中國大陸 35.465
保加利亞 4.750
Others 3.238 921 53
Total 148,435 1,197,450 612,767 269,636 177,412

圖形 - 格瑞那達 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

圖形 - 格瑞那達 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

表 - 格瑞那達 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

Date
Export Countries
 08 - 2024 09 - 2024 10 - 2024 11 - 2024 12 - 2024 01 - 2025
美國 28.803 2.995 4.050 16.989
比利時 42.553
法國 2.625 16.860
荷蘭 18.224
韩国 8.000 3.000
愛爾蘭 3.804
保加利亞 1.740 1.973
德國 2.345
瑞典 09
Total 73,981 39,819 12,318 6,804 4,050 16,998

圖形 - 格瑞那達 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

圖形 - 格瑞那達 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

表 - 格瑞那達 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

Date
Import Countries
 2021
瑞典 497
Total 497

圖形 - 格瑞那達 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

圖形 - 格瑞那達 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

表 - 格瑞那達 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

No Data Available

圖形 - 格瑞那達 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

圖形 - 格瑞那達 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

表 - 格瑞那達 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Importaciones
美國 109.639 780.783 344.567 89.989 35.848
韩国 4.000 28.000 250.000 21.000 26.000
荷蘭 13.153 141.608 1.402 51.269 18.224
巴拿馬 180.000
比利時 54.942 42.553
法國 11.705 13.936 32.287 21.581
愛爾蘭 7.258 10.784 13.940 20.034
德國 6.701 10.400 5.093 6.155 8.423
中國大陸 35.465
保加利亞 4.750
Others 3.238 921 53
Total 148,435 1,197,450 612,767 269,636 177,412

Date
Import Countries
 2021
Exportaciones
瑞典 497
Total 497

圖形 - 格瑞那達 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

圖形 - 格瑞那達 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

表 - 格瑞那達 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD

Date
Export Countries
 08 - 2024 09 - 2024 10 - 2024 11 - 2024 12 - 2024 01 - 2025
Importaciones
美國 28.803 2.995 4.050 16.989
比利時 42.553
法國 2.625 16.860
荷蘭 18.224
韩国 8.000 3.000
愛爾蘭 3.804
保加利亞 1.740 1.973
德國 2.345
瑞典 09
Total 73,981 39,819 12,318 6,804 4,050 16,998

Exportaciones
No Data Available